Xu-Yong Tian - Search Results

Year	Number of Results
2001	1
2002	2
2003	14
2004	24
2005	15
2006	16
2007	15
2008	9
2009	3
2010	17
2011	7
2012	7
2013	14
2014	7
2015	4
2016	4
2017	2
2018	3
2019	2
2020	3
2024	0

1

[Liposarcoma of the pleura: clinical characteristics].

Xiong WN, Fang HJ, Xu YJ, Xiong SD, Zhang HL, Zuo P. Xiong WN, et al. Among authors: xu yj. Zhonghua Jie He He Hu Xi Za Zhi. 2007 May;30(5):352-4. Zhonghua Jie He He Hu Xi Za Zhi. 2007. PMID: 17651641 Review. Chinese.

2

Expert consensus on acute exacerbation of chronic obstructive pulmonary disease in the People's Republic of China.

Cai BQ, Cai SX, Chen RC, Cui LY, Feng YL, Gu YT, Huang SG, Liu RY, Liu GN, Shi HZ, Shi Y, Song YL, Sun TY, Wang CZ, Wang JL, Wen FQ, Xiao W, Xu YJ, Yan XX, Yao WZ, Yu Q, Zhang J, Zheng JP, Liu J, Bai CX. Cai BQ, et al. Among authors: xu yj. Int J Chron Obstruct Pulmon Dis. 2014 Apr 25;9:381-95. doi: 10.2147/COPD.S58454. eCollection 2014. Int J Chron Obstruct Pulmon Dis. 2014. PMID: 24812503 Free PMC article. Review.

3

Primary pulmonary coccidioidomycosis in China.

Lan F, Tong YZ, Huang H, Xiong WN, Xu YJ, Xiong SD. Lan F, et al. Among authors: xu yj. Respirology. 2010 May;15(4):722-5. doi: 10.1111/j.1440-1843.2010.01747.x. Epub 2010 Apr 7. Respirology. 2010. PMID: 20409030

4

Mannose-binding lectin two gene polymorphisms and tuberculosis susceptibility in Chinese population: a meta-analysis.

Shi J, Xie M, Wang JM, Xu YJ, Xiong WN, Liu XS. Shi J, et al. Among authors: xu yj. J Huazhong Univ Sci Technolog Med Sci. 2013 Apr;33(2):166-171. doi: 10.1007/s11596-013-1091-1. Epub 2013 Apr 17. J Huazhong Univ Sci Technolog Med Sci. 2013. PMID: 23592124 Review.

5

Retraction Note: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma.

Wei S, Zhang ZY, Fu SL, Xie JG, Liu XS, Xu YJ, Zhao JP, Xiong WN. Wei S, et al. Among authors: xu yj. Cell Death Dis. 2019 Jan 25;10(2):60. doi: 10.1038/s41419-019-1300-3. Cell Death Dis. 2019. PMID: 30683838 Free PMC article.

6

Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma.

Wei S, Zhang ZY, Fu SL, Xie JG, Liu XS, Xu YJ, Zhao JP, Xiong WN. Wei S, et al. Among authors: xu yj. Cell Death Dis. 2017 May 25;8(5):e2829. doi: 10.1038/cddis.2017.254. Cell Death Dis. 2017. PMID: 28542138 Free PMC article.

7

[Chinese Journal of Tuberculosis and Respiratory Diseases plays an important role in promoting the study of chronic obstructive pulmonary disease in China].

Xu YJ, Liu XS. Xu YJ, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2004 Jan;27(1):12-4. Zhonghua Jie He He Hu Xi Za Zhi. 2004. PMID: 14989817 Review. Chinese. No abstract available.

8

Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma.

Wei S, Zhang ZY, Fu SL, Xie JG, Liu XS, Xu YJ, Zhao JP, Xiong WN. Wei S, et al. Among authors: xu yj. Cell Death Dis. 2016 Sep 29;7(9):e2388. doi: 10.1038/cddis.2016.260. Cell Death Dis. 2016. PMID: 27685632 Free PMC article. Retracted.

9

By downregulating Ku80, hsa-miR-526b suppresses non-small cell lung cancer.

Zhang ZY, Fu SL, Xu SQ, Zhou X, Liu XS, Xu YJ, Zhao JP, Wei S. Zhang ZY, et al. Among authors: xu yj. Oncotarget. 2015 Jan 30;6(3):1462-77. doi: 10.18632/oncotarget.2808. Oncotarget. 2015. PMID: 25596743 Free PMC article.

10

Correction to: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma.

Wei S, Zhang ZY, Fu SL, Xie JG, Liu XS, Xu YJ, Zhao JP, Xiong WN. Wei S, et al. Among authors: xu yj. Cell Death Dis. 2018 Aug 6;9(8):829. doi: 10.1038/s41419-018-0880-7. Cell Death Dis. 2018. PMID: 30082717 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

166 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

166 results

Results by year